Ravin Ratan

13PUBLICATIONS
98CO-AUTHORS
Molecular targetsPredictive and prognostic markersSocial epidemiologyCancer geneticsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study.

Mrinal Gounder, Patrick Schöffski, Robin L Jones

|Oct 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial.

Ravin Ratan, Bernd Kasper, Thierry Alcindor

|Sep 26, 2025
Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality.

Maureen E Canavan, Lee Cheng, Jenny Jing Xiang

|Sep 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.

Ryan A Denu, Richard K Yang, Alexander J Lazar

|Apr 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).

Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik

|Oct 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102).

Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik

Pageof 3